Breast density in women with premature ovarian failure using hormone therapy

References

• Harvey J A, Bovbjerg V E. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 2004; 230: 29–41
   PubMed Web of Science ®Google Scholar
• Luborsky J L, Meyer P, Sowers M F, Gold E B, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18: 199–206
   PubMed Web of Science ®Google Scholar
• Cramer D W. Epidemiologic aspects of early menopause and ovarian cancer. Ann N Y Acad Sci 1990; 592: 363–375
   PubMed Web of Science ®Google Scholar
• Cooper G S, Sandler D P. Age at natural menopause and mortality. Ann Epidemiol 1998; 8: 229–235
   PubMed Web of Science ®Google Scholar
• Bachmann G A. Androgen cotherapy in menopause: evolving benefits and challenges. Am J Obstet Gynecol 1999; 180: S312–S316
   PubMed Web of Science ®Google Scholar
• Harlow B L, Signorello L B. Factors associated with early menopause. Maturitas 2000; 35: 3–9
   PubMed Web of Science ®Google Scholar
• Armitage M, Nooney J, Evans S. Recent concerns surrounding HRT. Clin Endocrinol (Oxf) 2003; 59: 145–155
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative analyses of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350: 1047–1059
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, , Writing Group for the Women's Health Initiative Investigators, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
   PubMed Web of Science ®Google Scholar
• Warren R. Hormones and mammographic breast density. Maturitas 2004; 49: 67–78
   PubMed Web of Science ®Google Scholar
• El-Bastawissi A Y, White E, Mandelson M T, Taplin S H. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000; 11: 955–963
   PubMed Web of Science ®Google Scholar
• Vachon C M, Kuni C C, Anderson K, Anderson V E, Sellers T A. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000; 11: 653–662
   PubMed Web of Science ®Google Scholar
• Boyd N F, Rommens J M, Vogt K, Lee V, Hopper J L, Yaffe M J, Paterson A D. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005; 6: 798–808
   PubMed Web of Science ®Google Scholar
• de Moraes-Ruehsen M, Jones G S. Premature ovarian failure. Fertil Steril 1967; 18: 440–461
   PubMed Web of Science ®Google Scholar
• Treloar A E, Boynton R E, Behn B G, Brown B W. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967; 12: 77–126
   PubMedGoogle Scholar
• Cymberknoh M. Mamografia digital. Mastologia atual, E N Dias, M Caleffi, H MS Silva, A SS Figueira-Filho. Revinter, Rio de Janeiro 1994; 75–78
   Google Scholar
• Wolfe J N, Albert S, Belle S, Salane M. Breast parenchymal patterns and their relationship to risk for having or developing carcinoma. Radiol Clin North Am 1983; 21: 127–136
   PubMed Web of Science ®Google Scholar
• Altman D G. Statistics for medical research. Chapman and Hall, London 1987; 396–439
   Google Scholar
• Laya M B, Gallagher J C, Schreiman J S, Larson E B, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196: 433–437
   PubMed Web of Science ®Google Scholar
• Marugg R C, van der Mooren M J, Hendriks J H, Rolland R, Ruijs S H. Mammographic changes in postmenopausal women on hormonal replacement therapy. Eur Radiol 1997; 7: 749–755
   PubMed Web of Science ®Google Scholar
• Santos C C, Pinto-Neto A M, Costa-Paiva L HS, Brenelli H B. Efeitos da terapia hormonal na densidade mamográfica de mulheres na pós-menopausa. Reprod Clim 1998; 13: 117–122
   Google Scholar
• Sterns E E, Zee B. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?. Breast Cancer Res Treat 2000; 59: 125–132
   PubMed Web of Science ®Google Scholar
• Koukoulis G N. Hormone replacement therapy and breast cancer risk. Ann N Y Acad Sci 2000; 900: 422–428
   PubMed Web of Science ®Google Scholar
• Lundström E, Wilczek B, von Palffy Z, Söderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low potency estrogen regimens. Climateric 2001; 4: 42–48
   PubMedGoogle Scholar
• Christodoulakos G E, Lambrinoudaki I V, Vourtsi A D, Vlachou S, Creatsa M, Panoulis K P, Botsis D. The effect of low dose hormone therapy on mammographic breast density. Maturitas 2006; 54: 78–85
   PubMed Web of Science ®Google Scholar
• van Gils C H, Hendriks J H, Otten J D, Holland R, Verbeek A L. Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev 2000; 9: 105–111
   PubMed Web of Science ®Google Scholar
• Brisson J, Morrison A S, Kopans D B, Sadowsky N L, Kalisher L, Twaddle J A, Meyer J E, Henschke C I, Cole P. Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1984; 119: 371–381
   PubMed Web of Science ®Google Scholar